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Stability of diluted adenosine solutions in polyvinyl chloride infusion bags 
Abstract 
Purpose The stability of diluted adenosine solutions in polyvinyl chloride infusion bags was studied. 
Methods Adenosine 50-, 100-, and 220-μg/mL solutions were prepared in 50-mL polyvinyl chloride (PVC) 
infusion bags containing 0.9% sodium chloride injection or 5% dextrose injection and stored at room 
temperature (23–25 °C) or under refrigeration (2–8 °C). Each sample of every combination of 
concentration, diluent, and storage temperature was prepared in triplicate, yielding 36 samples. The 
samples were assayed using a stability-indicating, reverse-phase high-performance liquid 
chromatographic method immediately after preparation (time zero) and at 24 hours, 48 hours, 7 days, and 
14 days. pH was measured at time zero, 48 hours, 7 days, and 14 days. Time zero concentrations were 
calculated from the equation produced from a calibration curve of standards ranging from 10 to 500 μg/
mL. Samples were also visually inspected against a light background for clarity, color, and the presence of 
crystalline particulate matter. Stability was defined as retaining at least 90% of the initial adenosine 
concentration. 
Results After 14 days, all samples retained greater than 98% of the initial adenosine concentration, with 
no evidence of adsorption, visible precipitation, or considerable change in pH, suggesting minimal to no 
loss of product due to degradation or adsorption. 
Conclusion Adenosine 50-, 100-, and 220-μg/mL solutions in 50-mL PVC infusion bags containing 0.9% 
sodium chloride injection or 5% dextrose injection stored at room temperature and refrigerated conditions 
were stable for at least 14 days. 
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This article is available at Fisher Digital Publications: https://fisherpub.sjfc.edu/doctoral_ext_pub/28 
1 
 
 
 
 
 
 
 
 
 
 
Stability of diluted adenosine solutions in IV bags stored at two different temperatures  
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Abstract 
Purpose:  The objective of this study was to determine the stability of adenosine at 
concentrations of 50, 100, and 220 µg/ml in 50 ml IV bags of either 0.9% sodium chloride 
injection or 5% dextrose injection over the period of 14 days stored in the refrigerator (2-8°C) or 
at room temperature (23-25°C) using high performance liquid chromatography (HPLC). 
Methods:  Using aseptic techniques, adenosine solutions were prepared at concentrations of 50, 
100, and 220 µg/ml in 50 ml IV bags of 0.9% sodium chloride injection and 5% dextrose 
injection and stored at room temperature or refrigerated. Each sample of every combination of 
concentration, diluent, and storage temperature was made in triplicate for a total of 36 samples. 
The samples were visually inspected for microbial growth and assayed using high-performance 
liquid chromatography at time zero as well as 24 hours, 48 hours, 7 days, and 14 days. 
Measurements of pH were taken at time zero, 48 hours, 7 days, and 14 days. Time zero 
concentrations were calculated from the equation produced from a calibration curve of standards 
ranging from 10 µg/ml to 500 µg/ml. Stability was then defined as retaining ≥ 90% of the time 
zero concentration.  
Results:  After 14 days, all sample preparations contained greater than 90% of the initial (time 
zero) adenosine concentration with no evidence of adsorption, visible growth, or considerable 
change in pH. 
Conclusion:  Adenosine solutions of 50, 100, and 220 µg/ml concentrations in 50 ml IV bags of 
0.9% sodium chloride injection and 5% dextrose injection were stable when stored in the 
refrigerator or at room temperature for a period of at least 14 days.  
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Background 
Adenosine is an endogenous nucleoside present in all cells of the body. Clinically, it is 
used to convert paroxysmal supraventricular tachycardia to sinus rhythm. This is accomplished 
by the slowing of conduction time through the A-V node and by interrupting the reentry 
pathways through the A-V node.1  In recent years, there has been interest in the use of adenosine 
to restore hepatic artery flow (HAF) postoperative liver transplantation.  Currently, animal data 
has shown that restoring the hepatic artery buffer response results in improved survival.2  In this 
study, 9 female pigs received continuous infusions of adenosine at 0.7 µg/kg/minute until the 
HAF was greater than 250 ml/minute.  
Currently, an ongoing pilot study aims to demonstrate that adenosine infused into the 
hepatic artery of adult liver transplant recipients will produce an increase in HAF.  Low doses of 
adenosine ranging from 0.7-5.0 mcg/kg/minute are infused via a 16G central venous catheter line 
into a branch of the hepatic artery (normally ligated during liver transplant).  To maintain 
patency of the artery with sufficient flow from the catheter and simultaneously achieve low doses 
of adenosine, low concentrations are necessary for infusion into the catheter for up to 48 hours 
post-transplantation.  There is little data on the stability of diluted solutions of adenosine. One 
study reports adenosine diluted to 750 µg/ml with 0.9% sodium chloride injection, 5% dextrose 
injection, lactated Ringer’s injection, or 5% dextrose and lactated Ringer’s injection as being 
stable at 25, 5, and -15°C for at least 14 days.3  Because no information is available on the 
stability of adenosine solutions at lower concentrations, this study was designed to determine the 
stability of adenosine solutions of 50, 100, and 220 µg/ml prepared in 50 ml polyvinyl chloride 
(PVC) IV bags of 9% sodium chloride injection and 5% dextrose injection at room temperature 
(23-25°C) and refrigerated (2-8°C) for 14 days.  
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Methods 
 RP-HPLC 
A stability indicating reverse phase-high performance liquid chromatography (RP-HPLC) 
method using a Shimadzu model LC-2010A HT HPLC instrumenta with a C18 3.5 µm, 4.6 x 150 
mm columnb maintained at 40 °C was employed in this stability study. The Shimadzu instrument 
contained a degasser, autosampler, and UV detector within.  The UV detector was set at 259 nm, 
the wavelength at which adenosine is absorbed absorbs UV light.3 Shimadzu LC Solution 
software was used for data collection and processing. The mobile phase consisted of methanolc 
and distilled water (5:95 v/v) with 0.1% trifluoroacetic acidd.  Injections of 1 µl samples of 
adenosine eluted at a rate of 0.5 ml/min with an average retention time of 6 minutes.  
Assay Validation 
In accordance with guidelines provided by the American Journal of Hospital Pharmacy, a 
stability-indicating assay was used.4 A forced degradation study was conducted to show the 
ability of the assay to separate the degradation products from the parent drug. A stock solution 
was prepared by placing 10 mg of adenosine powdere in a 10 ml volumetric, with distilled water 
making up the remaining balance, and then stirred for 45 minutes to ensure complete dissolution. 
From the stock solution, four 100 µg/ml solutions, 10 ml each were prepared with distilled water 
as the diluents. Using a previously reported procedure, the samples were prepared as follows3 : 
Sample 1 was adjusted to pH 2 with 1M  hydrochloric acid and incubated at 60 °C for 95 hours. 
Sample 2 was adjusted to pH 12 with 1M sodium hydroxide and incubated at 60 °C for 95 hours. 
Sample 3 was spiked with 3% hydrogen peroxide (final concentration) and incubated at 60 °C 
for 95 hours. Sample 4 was spiked with 3% hydrogen peroxide and placed in a window sill in 
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direct sunlight for 95 hours.  RP-HPLC analysis was performed at time zero and at 95 hours for 
each sample.     
Standards of adenosine at 10, 50, 100, 300, and 500 µg/ml with distilled water as the 
diluents were prepared from a stock solution of 25 mg/ml. These standards were assayed by RP-
HPLC in triplicate on three consecutive days. Table 1 shows the intra-day variability of the 
assay. The inter-day results were calculated from the intra-day data and are shown in Table 2. 
At time zero, another set of standards were prepared using the same concentrations and 
method as the standards above. Using linear regression, a calibration curve was constructed of 
the peak area of adenosine against adenosine concentration. The curve was linear over the range 
of concentrations (r2 = 0.999). See Table 3 for the complete data.  
Stability Study 
 Before preparing the samples, the contents of three 50 ml bags of 9% sodium chloride 
injectionf of the same lot and three 50 ml bags of 5% dextrose injectiong of the same lot were 
emptied and measured to determine the overfill volume. The average overfill volume for each of 
the diluents was 7 ml. For each concentration being studied (50, 100, and 220 µg/ml), the 
volume of the adenosine solution to be injected was withdrawn from each bag along with the 7 
ml overfill. Adenosineh 50, 100, and 220 µg/ml samples were prepared in triplicate in either 9% 
sodium chloride injection or 5% dextrose injection and stored at room temperature (23-25 °C) or 
refrigerated (2-8 °C) for a total of 36 samples. All preparations were done using aseptic 
techniques in a class II biological safety cabineti.  
Visual inspection and RP-HPLC was performed at time zero, 24 hours, 48 hours, 7 days, 
and 14 days.  When the bags were removed from their controlled-temperature environments, a 
sample was collected and inspected against a light background to inspect for clarity, color and 
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the presence of crystalline particulate matter.  At time zero, 48 hours, 7 days, and 14 days, 2 ml 
of each sample was withdrawn for pH measurements. On each day that pH was measured, the pH 
meterj was calibrated with pH 4k and pH 7l buffer solutions yielding a slope ≥ 97% at 25.0 °C. 
The average of the pH values of each triplicate ± the standard deviation was calculated. For RP-
HPLC analysis, 1 ml was withdrawn from each sample. The equation y = 6450.1x – 21984 from 
the calibration curve was used to calculate the initial concentration as well as the percent of the 
initial concentration remaining using the average of the triplicate ± the standard deviation. 
Stability for this study was defined as ≥ 90% of the initial concentration remaining.  
Results and Discussion 
 At the start of the study, each sample was visually inspected with no precipitation found. 
Time zero concentrations and pH measurements were also recorded. At the end of the 14 day 
study, all samples remained clear and free of precipitation. All samples retained greater than 98% 
of the initial concentration at all time points, suggesting minimal if any loss of product due to 
degradation or adsorption (Table 4).  
 According to the manufacturers, the pH of adenosine 3 mg/ml solutionh is 5.5 – 7.5, 
0.9% sodium chloride injectionf is 4.5 – 7.0, and 5% dextrose injectiong is 3.2 – 6.5. Due to the 
small sample volume (2 ml) used and the wide range of values, the pH measurements were 
inconsistent and variable (Table 5). However, the pH of the samples with 0.9% sodium chloride 
were consistently higher (pH 6.24 – 8.07) than the pH of the samples with 5% dextrose (pH 5.80 
– 6.84). Another set of samples were prepared in the same manner to verify the accuracy of the 
time zero pH measurements. These samples also showed variability but remained in the same pH 
range.  
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Conclusion 
 Adenosine 50, 100, and 220 µg/ml solutions in 50 ml IV bags of 0.9% sodium chloride 
injection and 5% dextrose injection stored at room temperature and refrigerated conditions were 
stable for at least 14 days.  
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Footnotes 
aHPLC 2010A with LCSolutions. Shimadzu Scientific Instruments, Marlborough, MA. 
bSymmetry C18 column (3.5-µm particle size, 4.6 mm x 150 nm). Waters Corp., Milford, MA. 
cMethanol HPLC Grade. Fisher Scientific, Fair Lawn, NJ, lot 096609. 
dTrifluoroacetic acid, 99%. ACROS Organics, NJ, lot B0514618. 
eAdenosine, 99+%. ACROS Organics, NJ, lot A0263503 
f0.9% sodium chloride injection. Hospira, Inc., Lake Forest, IL, lot 74-025-JT 
g5% dextrose injection. Hospira, Inc., Lake Forest, IL, lot 69-249-JT. 
hAdenosine injection 6 mg/ml (3 mg/ml). Ben Venue Labs, Inc., Bedford, OH, lot 1360824. 
iESCO Airstream Class II Biological Safety Cabinet. ESCO Technologies, Hatboro, PA. 
jSevenEasy pH meter. Mettler-Toledo Inc., Columbus, OH. 
kBuffer solution pH 4.00. Fisher Scientific, Fair Lawn, NJ, lot 085812. 
lBuffer solution pH 7.00. Fisher Scientific, Fair Lawn, NJ, lot 084727. 
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Table 1.  Intra-day Variability Standard Results for Adenosine at 10, 50, 100, 300 and 500 μg/mL  
 Day 1 Standards 
Conc.   
     
µg/mla Area A Area B Area C 
Ave. 
          
Areab 
                                                   
Intra-day 
                 
Std.c 
Intra-day  
                                   
% CVd 
 
10 
 
61549 
 
61378 
 
61863 
 
61597 
 
246 
 
0.40 
50 302566 306729 306342 305212 2300 0.75 
100 609603 614814 607911 610776 3598 0.59 
300 1817457 1813071 1810339 1813622 3591 0.20 
500 3025820 3018918 3020640 3021793 3592 0.12 
 
Day 2 Standards 
 Conc.  
 
µg/mla  Area A Area B Area C 
Ave.   
        
Areab 
             
Intra-day  
 
Std.c 
Intra-day 
 
% CVd 
 
10 61393 60999 61801 61398 401 0.65 
50 305829 302480 302857 303722 1834 0.60 
100 616212 614914 614943 615356 741 0.12 
300 1825585 1805919 1802873 1811459 12328 0.68 
500 3005765 3023395 2998304 3009155 12884 0.43 
 
 
 
 
 
 
 
 
Day 3 Standards 
 
Conc.  
 
µg/mla  Area A Area B Area C 
Ave.   
              
Areab 
Intra-day 
 
 Std.c 
Intra-day    
 
 % CVd 
 
10 
 
61784 
 
61776 
 
61085 
 
61548 
 
401 
 
0.65 
50 302942 305830 327739 312170 13560 4.34 
100 610699 611201 611829 611243 566 0.09 
300 1807224 1808661 1798488 1804791 5506 0.31 
500 2999500 3005103 3000509 3001704 2987 0.10 
 
  aNominal concentration.  
  bAverage of areas A, B, and C. 
  cIntra-day standard deviation. 
 dIntra-day % coefficient of variation. 
 
Table 4.  Stability of Adenosine 50 μg/mL, 100 μg/mL and 220 μg/mL in 0.9% Sodium Infection 
and 5% Dextrose Injection Stored in Polyvinyl Chloride Bags     
 
Average 
Storage 
Temperature 
(°C)a 
 
 
 
 
Diluentb 
 
Actual Initial 
Drug 
Concentration 
(µg/ml)c 
 
                                                                                           
% Initial Concentration Remaining 
 
    24 hr             48 hr             7 days         14 days 
 
Nominal Concentration:  50 µg/ml 
5 NS 53.55 ± 0.41 99.4±0.3 99.5±0.7 99.7±0.5 98.6±0.7 
25 NS 53.15 ± 0.28 100.5±0.5 100.4±07 100.8±0.9 100.3±0.3 
5 D5W 52.41 ± 0.26 100.6±0.7   99.9±0.2 99.7±0.6 99.4±0.3 
25 D5W 52.04 ± 0.76 100.6±1.0 99.9±0.5 100.1±0.1 100.8±0.3 
Nominal Concentration:  100 µg/ml 
5 NS 107.39 ± 2.32 99.5±0.3 99.9±0.6 99.7±1.0 99.5±0.5 
25 NS 108.15 ± 1.17 99.7±0.1 99.7±0.2 99.6±0.3 100.5±0.8 
5 D5W 109.14 ± 5.00 100.5±0.8 99.5±0.9 99.6±1.0 100.1±1.3 
25 D5W 111.31 ± 2.18 99.7±0.5 99.2±0.4 99.4±0.6 99.6±0.3 
Nominal Concentration:  220 µg/ml 
5 NS 224.15 ± 2.76 101.1±0.6 99.7±1.0 99.9±1.3 99.2±1.1 
25 NS 232.63 ± 7.05 98.3±1.7 99.7±1.7 98.3±1.9 98.7±1.7 
5 D5W 231.28 ± 4.24 101.5±0.7 99.5±0.1 99.4±0.6 99.4±1.2 
 
 aRefrigerated temperature range 2 - 8°C. Room temperature range 23 - 25°C. 
bNS = 0.9% sodium chloride injection, 50 ml PVC IV bag.  
     D5W = 5% dextrose injection, 50 ml PVC IV bag. 
cMean ± S.D., n = 3. 
 
25 D5W 234.44 ± 1.37 
 
99.4±0.8 99.0±0.4 99.7±0.8 99.8±0.2 
1 
 
Table 5.  pH measurements of adenosine 50 μg/mL, 100 μg/mL and 220 μg/mL in 0.9% Sodium 
Infection and 5% Dextrose Injection Stored in Polyvinyl Chloride Bags 
 
Nominal 
Concentration 
(µg/ml) 
Average 
Storage 
Temperature 
(°C)a 
 
 
                       
Diluentb 
   
pH Measurement (Mean ± SD, n = 3) 
                                
  Time Zero           48 Hr             7 Days           14 Days  
   
 
                                
   
 
                         
   
 
                        
 
 
 
 
50 
 
5 
 
NS 
 
6.43 ± 0.19 
 
7.58±0.27 
 
7.71±0.13 
 
7.34±0.84 
50 25 NS 6.59 ± 0.08 8.00±0.06 8.00±0.19 6.83±0.26 
50 5 D5W 6.31 ± 0.28 6.86±0.07 6.77±0.13 6.48±0.32 
50 25 D5W 5.80 ± 0.74 6.80±0.03 6.67±0.11 6.41±0.26 
100 5 NS 6.24 ± 0.12 7.57±0.39 7.87±0.18 6.81±0.14 
100 25 NS 6.38 ± 0.17 7.88±0.14 8.07±0.04 6.78±0.03 
100 5 D5W 6.20 ± 0.34 6.78±0.07 6.32±0.59 6.24±0.28 
100 25 D5W 6.62 ± 0.08 6.71±0.04 6.64±0.09 6.16±0.59 
220 5 NS 7.31 ± 0.83 7.82±0.07 7.87±0.09 6.68±0.14 
220 25 NS 7.89 ± 0.02 7.95±0.02 7.83±0.11 6.70±0.17 
220 5 D5W 6.84 ± 0.06 6.84±0.03 6.69±0.02 6.18±0.29 
220 25 D5W 6.77 ± 0.06 6.76±0.11 6.70±0.04 6.45±0.23 
 
aRefrigerated temperature range 2 - 8°C. Room temperature range 23 - 25°C. 
bNS = 0.9% sodium chloride injection, 50 ml PVC IV bag.  
 D5W = 5% dextrose injection, 50 ml PVC IV bag. 
